Author name: Stanleylab

T-Ag Inhibits Implantation by EC Cell Derived Embryoid Bodies

A Espinosa and LP Villarreal   When introduced into ES cells of a blastocyct, polyomavirus (Py) T-Ag results in mice mosaic for T-Ag but otherwise essentially normal.  It has been reported that SV40 T-Ag does not inhibit differentiation of F9 EC cells, but did inhibit endogenous retrovirus (IAP) production.  We therefore sought to determine if …

T-Ag Inhibits Implantation by EC Cell Derived Embryoid Bodies Read More »

Stanley Lab: Picture index

Pictures       |  Staff   |   Mascot  | 5th Symposium  | Farewell Party for Dunja Hinze-Selch  |  Toxoplasma Meeting|                      Christmas 2000/Farewell Jing and Maja                                              

VIRUSES AND SCHIZOPHRENIA; A FOCUS ON HERPES SIMPLEX VIRUS

Herpes 11:2(Suppl):83A-88A, 2004 Robert Yolken ABSTRACT: Various factors have been implicated in the pathogenesis of schizophrenia. Evidence for an infectious cause includes the 508% increased risk among those born in the winter-spring months, when infectious diseases are more prevalent and at times when other infections (measles, varicella, poliomyelitis) show increased activity. Herpes simplex virus (HSV) …

VIRUSES AND SCHIZOPHRENIA; A FOCUS ON HERPES SIMPLEX VIRUS Read More »

TOXOPLASMA ANTIBODY TITERS IN TREATMENT NAIVE FIRST EPISODES OF SCHIZOPHRENIA

To explore the contribution of infectious exposure to schizophrenia, we determined the levels of several antibodies to infectious agents in blood samples collected in a randomized double-blind 52 week clinical trial in China.  The sample included 160 first-episode schizophrenia patients and 60 normal controls balanced in distribution of age (28 ±7), gender (53% male vs. …

TOXOPLASMA ANTIBODY TITERS IN TREATMENT NAIVE FIRST EPISODES OF SCHIZOPHRENIA Read More »

CENTRAL NERVOUS SYSTEM AND SYSTEMIC QUINOLINIC ACID IN SCHIZOPHRENIA

CENTRAL NERVOUS SYSTEM AND SYSTEMIC QUINOLINIC ACID IN SCHIZOPHRENIA LD Bobo*, RH Yolken, EF Torrey, JD Paltan-Ortiz, MM Herman, NC Briggs, H Velasco, M Zito, MP Heyes Stanley Research Foundation, NAMI, Washington DC Immunologic marker elevations in schizophrenia have been reported. Quinolinic acid (QUIN), a potential neurotoxic product of immune-activated macrophages and microglia, has been …

CENTRAL NERVOUS SYSTEM AND SYSTEMIC QUINOLINIC ACID IN SCHIZOPHRENIA Read More »

Welcome

The overall goal of The Stanley Neurovirology Laboratory of the Johns Hopkins University School of Medicine is to develop a training and research program devoted to the elucidation of the role of infection and immunity in the etiology of schizophrenia and bipolar disorders. Consumers: See Department/Programs

Comparative Immunovirological Investigations of HHV-6, HHV-7, and HHV-8 in Multiple Schlerosis (MS), Other Neurological Disorders (OND), and Healthy Donors (HD)

COMPARATIVE IMMUNOVIROLOGICAL INVESTIGATIONS OF HHV-6, HHV-7, AND HHV-8 IN MULTIPLE SCLEROSIS (MS), AND OTHER NEUROLOGICAL DISORDERS (OND), AND HEALTHY DONORS (HD) *D.V. Ablashi1,2, J. Friedman3, G. Pearson2, J. Zabriskie3, and J.E. Whitman1 1Advanced Biotechnologies Inc., Columbia, MD; 2Georgetown Univ Sch of Med, Washington DC; 3Lab of Clin Microbiology/Immunology, Rockefeller Univ New York, NY Previous reports …

Comparative Immunovirological Investigations of HHV-6, HHV-7, and HHV-8 in Multiple Schlerosis (MS), Other Neurological Disorders (OND), and Healthy Donors (HD) Read More »

ABSTRACT SUBMISSION

THE 7TH SYMPOSIUM ON THE NEUROVIROLOGY AND NEUROIMMUNOLOGY OF SCHIZOPHRENIA AND BIPOLAR DISORDER – FOCUS ON GENOMICS, PROTEOMICS AND CLINICAL TRIALS WAS A HUGH SUCCESS.   ABSTRACTS AND SLIDES FROM THE MEETING ARE NOW ON THIS SITE.  CLICK HERE TO VIEW  WE THANK EVERYONE FOR THEIR PARTICIPATION WE WILL NOT HAVE A GENERAL MEETING FOR 2002.  WE …

ABSTRACT SUBMISSION Read More »